| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |